180 related articles for article (PubMed ID: 12925142)
1. The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells.
Yoshida N; Ishikawa T; Ichiishi E; Yoshida Y; Hanashiro K; Kuchide M; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Yamamura Y; Okanoue T; Yoshikawa T
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():63-75. PubMed ID: 12925142
[TBL] [Abstract][Full Text] [Related]
2. Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
Masamune A; Yoshida M; Sakai Y; Shimosegawa T
J Pharmacol Exp Ther; 2001 Aug; 298(2):485-92. PubMed ID: 11454909
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines.
Aihara M; Azuma A; Takizawa H; Tsuchimoto D; Funakoshi Y; Shindo Y; Ohmoto Y; Imagawa K; Kikuchi M; Mukaida N; Matsushima K
Dig Dis Sci; 1998 Sep; 43(9 Suppl):174S-180S. PubMed ID: 9753246
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells.
Kim H; Seo JY; Kim KH
Dig Dis Sci; 2000 Mar; 45(3):621-8. PubMed ID: 10749342
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.
Hahm KB; Kim DH; Lee KM; Lee JS; Surh YJ; Kim YB; Yoo BM; Kim JH; Joo HJ; Cho YK; Nam KT; Cho SW
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():24-38. PubMed ID: 12925138
[TBL] [Abstract][Full Text] [Related]
6. The effect of rebamipide on the expression of proinflammatory mediators and apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins.
Kim JS; Kim JM; Jung HC; Song IS
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():45-54. PubMed ID: 12925140
[TBL] [Abstract][Full Text] [Related]
7. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.
Hayashi S; Sugiyama T; Amano K; Isogai H; Isogai E; Aihara M; Kikuchi M; Asaka M; Yokota K; Oguma K; Fujii N; Hirai Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):1895-9. PubMed ID: 9687380
[TBL] [Abstract][Full Text] [Related]
8. Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells.
Kang DW; Hwang WC; Park MH; Ko GH; Ha WS; Kim KS; Lee YC; Choi KY; Min DS
Oncogene; 2013 Jul; 32(30):3531-42. PubMed ID: 22890316
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.
Kim CD; Kim HH; Hong KW
J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.
Hayashi S; Sugiyama T; Yokota K; Isogai H; Isogai E; Shimomura H; Oguma K; Asaka M; Hirai Y
Microbiol Immunol; 2000; 44(7):557-62. PubMed ID: 10981828
[TBL] [Abstract][Full Text] [Related]
11. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
[TBL] [Abstract][Full Text] [Related]
12. Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells.
Maeda S; Akanuma M; Mitsuno Y; Hirata Y; Ogura K; Yoshida H; Shiratori Y; Omata M
J Biol Chem; 2001 Nov; 276(48):44856-64. PubMed ID: 11546774
[TBL] [Abstract][Full Text] [Related]
13. Rebamipide induces dendritic cell recruitment to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-exposed rat gastric mucosa based on IL-1β upregulation.
Yamamichi N; Oka M; Inada K; Konno-Shimizu M; Kageyama-Yahara N; Tamai H; Kato J; Fujishiro M; Kodashima S; Niimi K; Ono S; Tsutsumi Y; Ichinose M; Koike K
Biochem Biophys Res Commun; 2012 Jul; 424(1):124-9. PubMed ID: 22732404
[TBL] [Abstract][Full Text] [Related]
14. Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
Kang DW; Noh YN; Hwang WC; Choi KY; Min do S
Biochem Pharmacol; 2016 Aug; 113():36-44. PubMed ID: 27265143
[TBL] [Abstract][Full Text] [Related]
15. Alterations of epithelial permeability by Helicobacter and IL-1beta in vitro: protective effect of rebamipide.
Matysiak-Budnik T; Thomas-Collignon A; Mégraud F; Heyman M
Dig Dis Sci; 2001 Jul; 46(7):1558-66. PubMed ID: 11478510
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Helicobacter pylori-induced nuclear factor-kappa B activation and interleukin-8 gene expression by ecabet sodium in gastric epithelial cells.
Kim JM; Kim JS; Jung HC; Oh YK; Kim N; Song IS
Helicobacter; 2003; 8(5):542-53. PubMed ID: 14536001
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible?
Hahm KB; Song YJ; Oh TY; Lee JS; Surh YJ; Kim YB; Yoo BM; Kim JH; Han SU; Nahm KT; Kim MW; Kim DY; Cho SW
J Biochem Mol Biol; 2003 Jan; 36(1):82-94. PubMed ID: 12542979
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of rebamipide against Helicobacter pylori-CagA-induced effects on gastric epithelial cells.
Lee KH; Kim JY; Kim WK; Shin DH; Choi KU; Kim DW; Lee WJ; Choi JH; Lee SH; Kim GH; Song GA; Jeon TY; Kim CD; Hong KW; Park DY
Dig Dis Sci; 2011 Feb; 56(2):441-8. PubMed ID: 20556513
[TBL] [Abstract][Full Text] [Related]
19. Rebamipide protects against activation of neutrophils by Helicobacter pylori.
Yoshida N; Yoshikawa T; Iinuma S; Arai M; Takenaka S; Sakamoto K; Miyajima T; Nakamura Y; Yagi N; Naito Y; Mukai F; Kondo M
Dig Dis Sci; 1996 Jun; 41(6):1139-44. PubMed ID: 8654144
[TBL] [Abstract][Full Text] [Related]
20. Lymphotoxin β receptor signalling executes
Mejías-Luque R; Zöller J; Anderl F; Loew-Gil E; Vieth M; Adler T; Engler DB; Urban S; Browning JL; Müller A; Gerhard M; Heikenwalder M
Gut; 2017 Aug; 66(8):1369-1381. PubMed ID: 27196595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
